CN101822782A - Medicament for treating emphysema and preparation method thereof - Google Patents

Medicament for treating emphysema and preparation method thereof Download PDF

Info

Publication number
CN101822782A
CN101822782A CN 201010188832 CN201010188832A CN101822782A CN 101822782 A CN101822782 A CN 101822782A CN 201010188832 CN201010188832 CN 201010188832 CN 201010188832 A CN201010188832 A CN 201010188832A CN 101822782 A CN101822782 A CN 101822782A
Authority
CN
China
Prior art keywords
radix
fructus
medicine
medicament
emphysema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201010188832
Other languages
Chinese (zh)
Inventor
王旭亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201010188832 priority Critical patent/CN101822782A/en
Publication of CN101822782A publication Critical patent/CN101822782A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating emphysema, which is prepared from the following raw materials: radix codonopsitis, atractylis ovata, radix peucedani, milk veteh, dried orange peel, perillaseed, radish seed, ophiopogon root, shizandra berry, white mustard, balloon flower and fructus aurantii, the medicament can be prepared into multiple clinically used medicaments, an oral liquid is a preferred preparation form, and the medicament has good curative effect for emphysema, safe and reliable clinical application and no remarkable toxic or side effect.

Description

Emophysematous medicine of a kind of treatment and preparation method thereof
Technical field
The present invention relates to the emophysematous medicine of a treatment, specially referring to a kind of is the emophysematous medicine of treatment of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
In recent years, change along with life style and mode of operation, emphysema have become a kind of disease of high incidence more, emphysema are meant the air flue elasticity attenuation of terminal bronchiole far-end (alveolar bronchiole, alveolar duct, alveolar sac and alveolar), and excessive expansion, inflation and the increase of lung volume or while are with the destructive pathological state of airway walls.By its pathogenic factor emphysema following several types is arranged: aging-lung emphysema, compensatory emphysema, interstitial emphysema, kitchen range emphysema, other property emphysema at interval, obstructive emphysema.This disease is very big to the human injury, should enhance your vigilance, as early as possible treatment.
The emophysematous medicine of western medicine is more at present, diastole bronchus medicine, as aminophylline, beta 2 receptor analeptic, 17-hydroxy-11-dehydrocorticosterone etc., antibiotic at the pathogen use, as penicillin, gentamycin, ciprofloxacin, cephalosporin etc., and for example use effective antibiotic, as penicillin, gentamycin, ciprofloxacin, cephalosporin etc. according to pathogen or experience.These medicine life-time service are all very big to the side effect of human body, and these medicines are devoted to eliminate local disease, and model of action is single, and the recurrence easily of treatment back usually is difficult to radical cure.
The Chinese traditional treatment emphysema are special advantages especially, so be widely used.The traditional Chinese medical science thinks that emphysema are based on failure of the kidney in receiving QI, have insufficiency of lung-QI concurrently. the patient exhales easily air-breathing difficult, Changes in weather and have activity to cause slightly to pant.With vital energy benefiting and the kidney invigorating, it is main that expectorant falls in spleen invigorating to the traditional Chinese medical science to this sick Drug therapy.
Summary of the invention
The present invention aims to provide the emophysematous Chinese medicine of treatment that a kind of therapeutic effect is good, cost is low, have no side effect.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by following quality proportion raw material:
Radix Codonopsis 10-20 Rhizoma Atractylodis Macrocephalae 10-20 Radix Peucedani 10-20
Radix Astragali 10-25 Pericarpium Citri Reticulatae 10-20 Fructus Perillae 10-20
Semen Raphani 5-15 10-25 Radix Ophiopogonis Fructus Schisandrae Chinensis 5-15
Caulis et Folium Sinapis albee 5-15 Rhizoma Pinelliae 10-20 Fructus Aurantii 10-25.
The further quality proportioning of each component of medicine of the present invention is:
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 13 Radix Peucedanis 12
The Radix Astragali 20 Pericarpium Citri Reticulataes 13 Fructus Perillaes 13
Semen Raphani Fructus Schisandrae Chinensis 10 10 Radix Ophiopogonis 15
Caulis et Folium Sinapis albee 10 Radix Platycodoniss 12 Fructus Aurantiis 12.
The medicine of above-mentioned each component can be made said medicine on any pharmaceutics, and the preferred dosage form of the present invention is an oral liquid.
The concrete preparation method of medicine of the present invention comprises step:
Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Peucedani, the Radix Astragali, Pericarpium Citri Reticulatae, Fructus Perillae, Semen Raphani, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Caulis et Folium Sinapis albee, Radix Platycodonis, the Fructus Aurantii of getting above-mentioned mass fraction mix, and add the water of 2-4 times of dose, and water decocts after 20-40 minute and extracts filtrate.With the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.
The pharmacology analysis of each component is as follows among the present invention:
Radix Codonopsis: property is flat, sweet in the mouth, little acid.Return spleen, lung meridian, can invigorating the spleen and replenishing QI, the spleen invigorating lung benefiting is used for symptoms such as deficiency of the spleen and lung;
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature is returned spleen, stomach warp, invigorating the spleen and benefiting QI, and the dampness diuretic, hidroschesis, antiabortive etc.;
Radix Peucedani: cold nature, bitter in the mouth, suffering are returned lung, spleen, Liver Channel, dispelling wind and heat pathogens; Lowering the adverse-rising QI to resolve phlegm;
The Radix Astragali: can tonify deficiency, control the stringy pulse spontaneous perspiration, rush down YIN-fire, remove lung-heat, losslessly then send out, there is antiperspirant then to end;
Pericarpium Citri Reticulatae: temperature; Hot, bitter, return spleen, lung meridian, regulating qi-flowing for strengthening spleen, in the accent, dampness is reduced phlegm;
Fructus Perillae: suffering, temperature.Return lung meridian, the sending down the abnormal ascending QI expectorant is relievingd asthma, intestine moistening;
Semen Raphani: property is flat, and acrid in the mouth, sweet is returned lung, spleen, stomach warp; Help digestion to remove and expand lowering the adverse-rising QI to resolve phlegm;
Radix Ophiopogonis: sweet, little hardship, be slightly cold, GUIXIN, lung, stomach warp, Yin and promoting production of body liquid, lung moistening clears away heart-fire, and is used for dryness of the lung dry cough, the chronic consumptive disease cough, Tianjin wound is thirsty etc.;
Fructus Schisandrae Chinensis: temperature, sour, sweet, return lung, the heart, kidney channel, restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.
Caulis et Folium Sinapis albee: acrid in the mouth, temperature is gone into lung, warming spleen and stomach for dispelling cold;
Radix Platycodonis: bitter in the mouth, suffering, slightly warm in nature is gone into lung meridian, the energy expelling phlegm for arresting cough, and lung qi dispersing, evacuation of pus effect are arranged;
Fructus Aurantii: the nature and flavor hardship, acid, cold nature is returned lung, spleen, liver, stomach, large intestine channel, treatment septum pectorale feeling of fullness, distending pain over the hypochondrium, accumulation of food in the stomach and intes tine due to indigestion, distension and fullness in the abdomen etc.;
The traditional Chinese medical science is thought, emphysema are often relevant with the hepatic and renal YIN deficiency, the Chinese traditional treatment emphysema are earlier eliminating evil, are equipped with yang-energy and transfer benefit, existing nourishing YIN and supplementing blood in the side, the composition that the invigorating YANG QI invigorating is arranged again, all medicine reasonable compatibilities, complementary collaborative, dialectical treatment, we remove tired sending down the abnormal ascending QI, for by insufficiency of the spleen, suffer from a deficiency of the kidney and diseases such as emphysema that the deficiency of the lung causes have better curative effect.
During treatment, this medicine was taken for three times morning, noon, the late branch.
Actual efficacy for checking medicine of the present invention, use medicine of the present invention and cooperate the clinical treatment emphysematic patients, 86 examples, result are cured 63 examples, and cure rate is 73.3%, 19 examples are clearly better, total effective rate 95.3%, clinical test results prove that curative effect of medication of the present invention is definite, and have no side effect, clinical practice is safe and reliable.Drug price of the present invention is comparatively cheap.
The specific embodiment
Prepare raw material according to following weight:
Radix Codonopsis 1.5kg, Rhizoma Atractylodis Macrocephalae 1.3kg, Radix Peucedani 1.2kg, Radix Astragali 2kg, Pericarpium Citri Reticulatae 1.3kg, Fructus Perillae 1.3kg, Semen Raphani 1kg, Radix Ophiopogonis 1.5kg, Fructus Schisandrae Chinensis 1kg, Caulis et Folium Sinapis albee 1kg, Radix Platycodonis 1.2kg, Fructus Aurantii 1.2kg.
Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Peucedani, the Radix Astragali, Pericarpium Citri Reticulatae, Fructus Perillae, Semen Raphani, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Caulis et Folium Sinapis albee, Radix Platycodonis, the Fructus Aurantii of getting above-mentioned mass fraction mix, and add the water of 2-4 times of dose, and water decocts after 20-40 minute and extracts filtrate.With the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.

Claims (4)

1. treat emophysematous medicine for one kind, it is characterized in that described medicine is the medicament of being made by following quality proportion raw material:
Radix Codonopsis 10-20 Rhizoma Atractylodis Macrocephalae 10-20 Radix Peucedani 10-20
Radix Astragali 10-25 Pericarpium Citri Reticulatae 10-20 Fructus Perillae 10-20
Semen Raphani 5-15 10-25 Radix Ophiopogonis Fructus Schisandrae Chinensis 5-15
Caulis et Folium Sinapis albee 5-15 Rhizoma Pinelliae 10-20 Fructus Aurantii 10-25.
2. the emophysematous medicine of treatment according to claim 1 is characterized in that described medicine is the medicament of being made by following quality proportion raw material:
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 13 Radix Peucedanis 12
The Radix Astragali 20 Pericarpium Citri Reticulataes 13 Fructus Perillaes 13
Semen Raphani Fructus Schisandrae Chinensis 10 10 Radix Ophiopogonis 15
Caulis et Folium Sinapis albee 10 Radix Platycodoniss 12 Fructus Aurantiis 12.
3. the emophysematous medicine of treatment according to claim 1 and 2 is characterized in that described medicament is an oral liquid.
4. the preparation method of treatment emphysema medicine according to claim 3, the Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Peucedani, the Radix Astragali, Pericarpium Citri Reticulatae, Fructus Perillae, Semen Raphani, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Caulis et Folium Sinapis albee, Radix Platycodonis, the Fructus Aurantii that it is characterized in that getting above-mentioned mass fraction mix, the water that adds 2-4 times of dose, water decocts after 20-40 minute and extracts filtrate, with the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.
CN 201010188832 2010-05-26 2010-05-26 Medicament for treating emphysema and preparation method thereof Pending CN101822782A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010188832 CN101822782A (en) 2010-05-26 2010-05-26 Medicament for treating emphysema and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010188832 CN101822782A (en) 2010-05-26 2010-05-26 Medicament for treating emphysema and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101822782A true CN101822782A (en) 2010-09-08

Family

ID=42687087

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010188832 Pending CN101822782A (en) 2010-05-26 2010-05-26 Medicament for treating emphysema and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101822782A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631457A (en) * 2011-12-13 2012-08-15 中国人民解放军海军总医院 Medicine composite for lowering pulmonary artery pressure and preparation method thereof
CN104873747A (en) * 2015-04-24 2015-09-02 安徽智远生物科技有限公司 Traditional Chinese medicine decoction for moistening lung and relieving cough
CN105079355A (en) * 2015-09-23 2015-11-25 谢桂斌 Medicine for treating senile emphysema

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312103A (en) * 2001-02-23 2001-09-12 邓万发 Chinese medicine for treating dyspneic cough effectively

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312103A (en) * 2001-02-23 2001-09-12 邓万发 Chinese medicine for treating dyspneic cough effectively

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《河北中医》 20040930 焦树德 治咳七法 第645-648页 1-3 第26卷, 第9期 2 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631457A (en) * 2011-12-13 2012-08-15 中国人民解放军海军总医院 Medicine composite for lowering pulmonary artery pressure and preparation method thereof
CN104873747A (en) * 2015-04-24 2015-09-02 安徽智远生物科技有限公司 Traditional Chinese medicine decoction for moistening lung and relieving cough
CN105079355A (en) * 2015-09-23 2015-11-25 谢桂斌 Medicine for treating senile emphysema

Similar Documents

Publication Publication Date Title
CN101797347B (en) Traditional Chinese medicinal composition for treating gastrointestinal tract and preparation thereof
CN101972443B (en) Chinese medicinal formula for treating chronic gastritis
CN103386008A (en) Chinese medicine composition for treating endocrine dyscrasia
CN103736061A (en) Traditional Chinese medicine composition for treating stomach distension
CN102973874A (en) Traditional Chinese medicine relieving hiccup
CN100431570C (en) Medicine for treating idiopathy thrombocytopenia peliosis
CN102274466B (en) Chinese medicinal composition for treating gastritis
CN101822795A (en) Medicament for treating chronic tracheitis and preparation method thereof
CN101822782A (en) Medicament for treating emphysema and preparation method thereof
CN104001131B (en) A kind of Chinese medicine for oral administration preventing and treating stress ulcer
CN104042713B (en) A kind of Chinese medicine composition for the treatment of bronchial asthma
CN103566109B (en) The kidney invigorating asthma relieving powder
CN105079444A (en) Traditional Chinese medicine composition for treating bronchial asthma
CN101953979A (en) Medicament for treating esophagitis
CN107596244A (en) One kind treats cardiopathic Chinese medicine and preparation method thereof
CN103463588A (en) Traditional Chinese medicine composition for treating sinking of qi of middle-jiao
CN103495130B (en) Traditional Chinese medicine composition for treating asthma
CN101856452A (en) Medicament for treating bronchitis and preparation method thereof
CN104225211A (en) Traditional Chinese medicine composition for treating emphysema and preparation method thereof
CN105497738A (en) Gastroptosis treating traditional Chinese medicine composition
CN104721435A (en) Cough and asthma relieving powder
CN103028063B (en) Traditional Chinese medicine composition for treating nephropathy
CN102895351A (en) Drug for treating trachitis and preparation method for drug
CN102406879A (en) Chinese medicine composition for treating rhinitis
CN101129537A (en) Orally taken traditional Chinese medicine composition for treating irritable bowel syndrome

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100908